Related Experiment Video

Updated: Jul 16, 2026

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Drug resistance in melanoma: new perspectives

Caterina A M La Porta1

  • 1Department of Biomolecular Science and Biotechnology, University of Milan, Italy. caterina.laporta@unimi.it

Current Medicinal Chemistry
|February 20, 2007
PubMed

Insights

Melanoma cells resist chemotherapy by evading apoptosis and utilizing multidrug resistance (MDR) transporters. Novel strategies targeting cancer stem cells may improve melanoma treatment efficacy.

Area of Science:

  • Oncology
  • Cancer Biology
  • Pharmacology

Background:

  • Melanoma, an aggressive skin cancer, exhibits resistance to conventional therapies.
  • Melanoma cell resistance is linked to apoptosis evasion, promoting tumor progression and metastasis.
  • Multidrug resistance (MDR) transporters play a crucial role in melanoma chemoresistance.

Purpose of the Study:

  • To review the discovery and mechanisms of MDR transporters in melanoma.
  • To explore the apoptotic pathways exploited by melanoma cells.
  • To discuss novel therapeutic strategies for overcoming melanoma chemoresistance, including targeting cancer stem cells.

Main Methods:

  • Literature review of MDR transporters and melanoma apoptosis.
  • Analysis of cancer stem cell hypothesis in melanoma resistance.
  • Evaluation of strategies to reverse MDR and enhance therapeutic index.

Main Results:

  • Melanoma cells employ MDR transporters and resist apoptosis, contributing to therapeutic failure.
  • Cancer stem cell hypothesis offers insights into persistent melanoma populations.
  • MDR reversal agents show potential but require further optimization.

Conclusions:

  • Understanding MDR transporters and apoptosis is key to overcoming melanoma resistance.
  • Targeting cancer stem cells presents a promising avenue for improving melanoma treatment outcomes.
  • Future research should focus on enhancing the efficacy of MDR reversal agents and combination therapies.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...